If process is product, mustn’t quality be top of strategy in Indian pharma?

  In the tsunami of Bihar election news, a significant development got swept away last weekend. It was the announcement by Dr Reddy’s Laboratories that three of its manufacturing plants in India had received US FDA warning letters. Today, Mint reports that the American regulator has sought third party audit across the pharma company’s entire […]

Biocon-Pfizer Breakup: Why Diabetes Alliances Don’t Work for Indian pharma?

In a very surprising move, Pfizer and Biocon announced today that they have called off their 17-month old commercialization alliance for generic insulin. “The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently,” said the press release. This was followed […]

Biocon-Pfizer Breakup: Why Diabetes Alliances Don't Work for Indian pharma?

In a very surprising move, Pfizer and Biocon announced today that they have called off their 17-month old commercialization alliance for generic insulin. “The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently,” said the press release. This was followed […]